tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xenon Pharmaceuticals joins Russell 3000, Russell 2000 Indexes
PremiumThe FlyXenon Pharmaceuticals joins Russell 3000, Russell 2000 Indexes
25d ago
Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees
Premium
Company Announcements
Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees
25d ago
Xenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer to Drive Commercial Launch
Premium
Company Announcements
Xenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer to Drive Commercial Launch
28d ago
Xenon Pharmaceuticals Announces Equity Inducement Grants for New Employees
PremiumCompany AnnouncementsXenon Pharmaceuticals Announces Equity Inducement Grants for New Employees
2M ago
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Optimism
Premium
Company Announcements
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Optimism
2M ago
Xenon’s Azetukalner: Strong Phase 2b Data and Financial Stability Support Buy Rating Despite Trial Delays
Premium
Ratings
Xenon’s Azetukalner: Strong Phase 2b Data and Financial Stability Support Buy Rating Despite Trial Delays
2M ago
Confident Buy Rating for Xenon Amid X-TOLE2 Study Delays and Promising Azetukalner Results
PremiumRatingsConfident Buy Rating for Xenon Amid X-TOLE2 Study Delays and Promising Azetukalner Results
2M ago
Xenon Pharmaceuticals Advances Clinical Programs Amid Financial Loss
Premium
Company Announcements
Xenon Pharmaceuticals Advances Clinical Programs Amid Financial Loss
2M ago
Xenon Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Trials and Financial Stability
Premium
Ratings
Xenon Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Trials and Financial Stability
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100